CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- 4 Grant or award Director acquired 54,500 shares (grant or award)
- 4 Open-market sale Vargeese Chandra sold 1,500 shares at $35.00 ($52,500)
- 4 Open-market buy Director bought 423,398 shares at an average $23.34 ($9,881,550)
- 4 Open-market sale Director sold 20,747 shares at an average $24.21 ($502,301)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Franchise Lead, Neurology sold 7,414 shares at $16.67 ($123,620)
- 4 Open-market sale Director sold 433,825 shares at $24.91 ($10,806,581)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Vargeese Chandra acquired 9,800 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 4,300 shares (grant or award)
- 4 Grant or award Director acquired 36,300 shares (grant or award)
- 4 Grant or award Head of Neurology Franchise acquired 6,900 shares (grant or award)
- 4 Grant or award Francis Chris acquired 9,800 shares (grant or award)
- 4 Exercise or conversion GUERCIOLINI ROBERTO acquired 24,000 shares (option exercise)
Page 12 of 14 · 274 filings